• Monitoring of Cyclosporine A in liver transplant patients. Cyclosporine A HPLC Workshop, University of Liverpool, September 1986.

• Speaker and co-chairman. Symposium on organ transplantation. Second International Conference on Surgery in the Tropics. SN Chatterji (USA), C Kurvila (USA), Motiwala (India) Bombay, India, February 1987.

• Cadaveric organ transplantation. T. N. Medical College, Bombay, India, February 1987.

• Liver transplantation in Europe L.T.Medical College, Bombay, India, February 1987.

• Liver transplantation in Birmingham. Bombay Hospital, February 1987.

• Liver Transplantation at Jaslok Hospital, February 1987.

• New immunosuppressive agents. Bombay Hospital, Bombay , India, October 1988.

• Clinical update and kinetics of FK506 at Queen Elizabeth Hospital, Birmingham, UK, April 1990.

• Liver transplantation today. First International Workshop (Neurological Problems and Liver Transplantation). Bologna, Italy, May 8, 1998.

• Chair session on immunosupression with Sir Roy Caln at Fifth Congress of the International Liver Transplantation Society, Pittsburgh, PA, August 26-28, 1999.

• Management of HCV in renal transplant patients. 7th Congress of the Asian Society of Transplantation, New Delhi, India, March 2-6, 2002.

• Advances in liver transplantation in hepatitis B and C. 7th Congress of the Asian Society of Transplantation, New Delhi, India, March 2-6, 2002.

• Alcoholic liver disease and transplantation. 7th Congress of the Asian Society of Transplantation, New Delhi, India, March 2-6, 2002.

• Co-chaired Current status of small bowel transplantation. 7th Congress of the Asian Society of Transplantation, New Delhi, India, March 2-6, 2002.

• Living Donor Liver Transplantation: Ethics and safety. 7th Congress of the Asian Society of Transplantation, New Delhi, India, March 2-6, 2002.

• Immunosuppression in liver Transplantation and role of mycophenolate Mofetil: Liver Transplantation conference, Nagasaki Japan, April 10, 2003.

• Advisory Board: 2nd Annual Liver Disease Conference, Newport RI, September 18-21, 2003.

Reviewer for Journals

Abstracts

• Abstract reviewer for First International Congress on FK 506. Pittsburgh , PA , August 1991

• Abstract reviewer for Fifth Congress of the International Liver Transplantation Society, Pittsburgh , PA , August 1999.

Peer Reviewed Journals

• Transplantation.

• Gastroenterology

• Liver Transplantation and Surgery/Liver Transplantation

• Digestive Diseases and Sciences

• AIDS International

• Lancet

• New England Journal of Medicine

University and Medical School Services

• Member of committee 1991 to present and review clinical data collection and identify causes of graft loss and death at Thomas E. Starzl Transplantation Institute.

• October 1992 – December 1993: Retrospective collection of adverse events in over 3000 solid-organ transplant recipients under tacrolimus in preparation to FDA approval of investigational drug FK-506.

• In-service to transplant coordinators and nurses on transplant floor at Presbyterian hospital and Children’s Hospital on new immunosuppressive agents about once a year.

• Adviser in developing clinical trials to Thomas E. Starzl Transplantation Institute.

• Adviser in developing drug interaction and drug metabolism protocol to School of Pharmacy in transplant-related patients.

• Committee member for transplant information management system 1989 to 1995.

• Committee member for electronic data interchange for transplant 1998 onwards.

• Review transplant protocol for Thomas E. Starzl Transplantation Institute for IRB submission.

• Review clinical trial for safety of Cyclosporine inhalation in lung transplant patient.

• Committee member for data safety and monetary of IRB protocols within transplant division.

• Retrospective collection of medication, organization and supervision in post-liver transplant patients.

Community Activities

• Helping with donor awareness week once a year.

• Distributing Donor Cards to ethnic community.

• Demonstration of transplant program to medical and non-medical visitors from U.S.A. and out of U.S.A.

• Providing consultation on phone and/or medical reports and/or radiological findings for suitability of transplantation, timing of transplantation and resectability of hepatic cancer, prognostic aspects of the disease from patients referred within U.S.A. and outside U.S.A.

Professional Consulting

• Dosing and adverse events of new immunosuppressive agents FK 506 in liver transplantation. 1989 –1991 at Queen Elizabeth Hospital, Birmingham, U.K.

• Telephonic Consultation for difficult and controversial clinical issues with liver transplantation to other transplant centers, e.g., University of California, San Diego Transplant Division.